The Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, pre-mRNA splicing, and DNA damage response. Using CLIP-seq, we identified EWS RNA binding sites in exonic regions near 5′ splice sites. A prominent target was exon 6 of the FAS/CD95 receptor, which is alternatively spliced to generate isoforms with opposing activities in programmed cell death. Depletion and overexpression experiments showed that EWS promotes exon 6 inclusion and consequently the synthesis of the proapoptotic FAS/CD95 isoform, whereas an EWS-FLI1 fusion protein characteristic of Ewing sarcomas shows decreased activity. Biochemical analyses revealed that EWS binding promotes the recruitment of U1snRNP and U2AF65 to the splice sites fl...
Ewing sarcoma is driven by fusion proteins containing a low-complexity (LC) domain that is intrinsic...
Background: EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangem...
Ewing sarcomas (ES) are highly malignant bone or soft tissue tumors. Genetically, ES are defined by ...
SummaryThe Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, ...
The Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, pre-mRN...
<p><b>A</b>. Protein domain organization of EWS and FLI1. The black vertical arrows indicate common ...
Genetic translocation of EWSR1 to ETS transcription factor coding region is considered as primary ca...
Ewing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an a...
<div><p>Genetic translocation of EWSR1 to ETS transcription factor coding region is considered as pr...
EWS-Fli1 is an oncogenic transcription factor that causes Ewing sarcoma. EWS-Fli1 is a fusion protei...
SummaryEwing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Usi...
EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangement, specifi...
International audienceEwing sarcoma is the second most frequent pediat-ric bone tumor. In most of th...
SummaryOur understanding of Ewing's sarcoma development mediated by the EWS/FLI fusion protein has b...
Fused in Sarcoma (FUS), Ewing Sarcoma (EWSR1), and TATA-Box Binding Protein Associated Factor 15 (TA...
Ewing sarcoma is driven by fusion proteins containing a low-complexity (LC) domain that is intrinsic...
Background: EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangem...
Ewing sarcomas (ES) are highly malignant bone or soft tissue tumors. Genetically, ES are defined by ...
SummaryThe Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, ...
The Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, pre-mRN...
<p><b>A</b>. Protein domain organization of EWS and FLI1. The black vertical arrows indicate common ...
Genetic translocation of EWSR1 to ETS transcription factor coding region is considered as primary ca...
Ewing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an a...
<div><p>Genetic translocation of EWSR1 to ETS transcription factor coding region is considered as pr...
EWS-Fli1 is an oncogenic transcription factor that causes Ewing sarcoma. EWS-Fli1 is a fusion protei...
SummaryEwing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Usi...
EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangement, specifi...
International audienceEwing sarcoma is the second most frequent pediat-ric bone tumor. In most of th...
SummaryOur understanding of Ewing's sarcoma development mediated by the EWS/FLI fusion protein has b...
Fused in Sarcoma (FUS), Ewing Sarcoma (EWSR1), and TATA-Box Binding Protein Associated Factor 15 (TA...
Ewing sarcoma is driven by fusion proteins containing a low-complexity (LC) domain that is intrinsic...
Background: EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangem...
Ewing sarcomas (ES) are highly malignant bone or soft tissue tumors. Genetically, ES are defined by ...